AVITA Medical (AVHHL) Total Non-Current Liabilities (2018 - 2026)
AVITA Medical's (AVHHL) quarterly Total Non-Current Liabilities came in at $74.7 million in Q2 2026, up 8.19% on a YoY basis from $69.1 million in Q2 2025, and up 6.7% quarter-over-quarter from $70.0 million in Q4 2025.
Analysis
AVITA Medical (AVHHL) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
AVITA Medical (AVHHL) has reported Total Non-Current Liabilities for 9 consecutive years, with $74.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Non-Current Liabilities rose 8.19% year-over-year to $74.7 million; the trailing twelve-month figure through Jun 2026 stood at $74.7 million (up 8.19% YoY), and the FY2025 full-year result was $70.0 million, down 2.09% from the prior year.
- Total Non-Current Liabilities rose to $74.7 million in Q2 2026 per AVHHL's latest filing, from $70.0 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $74.7 million in Q2 2026 and bottomed at $8.1 million in Q1 2022.
- Historically, Total Non-Current Liabilities has averaged $53.8 million across 5 years, with a median of $65.8 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities dropped 11.18% in 2022, then surged 405.49% in 2023.
- Over 5 years, Total Non-Current Liabilities stood at $11.6 million in 2022, then soared by 405.49% to $58.7 million in 2023, then advanced by 21.8% to $71.5 million in 2024, then slipped by 2.09% to $70.0 million in 2025, then gained by 6.7% to $74.7 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $74.7 million, $70.0 million, and $68.5 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.89 Bn | 179.29 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.33 Bn | 119.12 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 104.48 Bn | 101.01 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 66.98 Bn | 66.44 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.79 Bn | 45.54 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 33.96 Bn | 32.50 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn | 3.44 Bn |
| 10 | AVITA Medical | 61.85 Mn | 50.72 Mn | 17.77 Mn | 74.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 74.74 Mn |
| Dec 31, 2025 | 70.04 Mn |
| Sep 30, 2025 | 68.53 Mn |
| Jun 30, 2025 | 69.08 Mn |
| Mar 31, 2025 | 71.01 Mn |
| Dec 31, 2024 | 71.54 Mn |
| Sep 30, 2024 | 65.84 Mn |
| Jun 30, 2024 | 61.55 Mn |
| Mar 31, 2024 | 59.96 Mn |
| Dec 31, 2023 | 58.73 Mn |
| Dec 31, 2022 | 11.62 Mn |
| Jun 30, 2022 | 9.23 Mn |
| Mar 31, 2022 | 8.11 Mn |
| Dec 31, 2021 | 11.28 Mn |
| Sep 30, 2021 | 9.18 Mn |
| Jun 30, 2021 | 9.34 Mn |
| Mar 31, 2021 | 9.13 Mn |
| Jun 30, 2020 | 10.06 Mn |
| Jun 30, 2019 | 465,625.64 |
| Jun 30, 2018 | 101,698.83 |